1. Home
  2. DSGR vs DBVT Comparison

DSGR vs DBVT Comparison

Compare DSGR & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Distribution Solutions Group Inc.

DSGR

Distribution Solutions Group Inc.

HOLD

Current Price

$30.97

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$20.70

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSGR
DBVT
Founded
1952
2002
Country
United States
France
Employees
N/A
117
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DSGR
DBVT
Price
$30.97
$20.70
Analyst Decision
Buy
Buy
Analyst Count
1
7
Target Price
$41.00
$31.75
AVG Volume (30 Days)
88.7K
477.4K
Earning Date
03-05-2026
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,978,887,000.00
$5,502,000.00
Revenue This Year
$12.80
$1,768.71
Revenue Next Year
$4.23
$1,028.88
P/E Ratio
N/A
N/A
Revenue Growth
14.46
N/A
52 Week Low
$21.87
$3.82
52 Week High
$33.80
$26.19

Technical Indicators

Market Signals
Indicator
DSGR
DBVT
Relative Strength Index (RSI) 60.47 51.93
Support Level $30.56 $20.85
Resistance Level $31.68 $24.65
Average True Range (ATR) 0.97 1.47
MACD 0.15 -0.24
Stochastic Oscillator 72.07 33.33

Price Performance

Historical Comparison
DSGR
DBVT

About DSGR Distribution Solutions Group Inc.

Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education and medical industries.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: